TSE: 4886 - ASKA Pharmaceutical Holdings Co.,Ltd.

Yield per half year: +3.37%
Dividend yield: +3.07%
Sector: Healthcare

Share chart ASKA Pharmaceutical Holdings Co.,Ltd.

en.porti.ru300030002700270024002400210021001800180015001500Dec '23Dec '2320242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25
Download SVG
Download PNG
Download CSV

About ASKA Pharmaceutical Holdings Co.,Ltd.

ASKA Pharmaceutical Holdings Co.,Ltd. через свои дочерние компании занимается фармацевтическим, ветеринарным и гормональным бизнесом в Японии. Компания исследует, разрабатывает, производит и продает фармацевтическую продукцию в области эндокринологии, акушерства и гинекологии и урологии; и исследует, производит, продает, импортирует и экспортирует ветеринарные лекарства, ветеринарные медицинские изделия, корма и кормовые добавки, реагенты, агрохимикаты, промышленные химикаты, средства гигиены, а также продукты питания и их сырье.

more details
Он также участвует в клинических исследованиях и биологических испытаниях; и предлагает медицинское оборудование. Компания была основана в 1920 году, ее штаб-квартира находится в Токио, Япония.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Див.доход ао 3.23
Дивиденд ао 25
Сайт https://www.aska-pharma-hd.co.jp
Цена ао 2324
Change price per day: +2.32% (2246)
Change price per week: +9.79% (2093)
Change price per month: -0.82% (2317)
Change price per 3 month: +15.02% (1998)
Change price per half year: +3.37% (2223)
Change price per year: +1.68% (2260)
Change price per year to date: +11.28% (2065)
All parameters

Underestimation

Title Value Grade
P/S 1 9
P/BV 1.02 9
P/E 8.37 9
EV/EBITDA 4.69 10
Total: 7.38

Efficiency

Title Value Grade
ROA, % 8.48 3
ROE, % 12.96 4
Total: 4

Dividends

Title Value Grade
Div yield, % 3.07 7.68
DSI 0.9167 9.17
Total: 5.27

Debt

Title Value Grade
Debt/EBITDA 0.7548 9
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % 19.61 3
Yield Ebitda, % 138.46 10
Yield EPS, % 1061.66 10
Total: 6.6
More

Institutions Volume Share, %
DFA International Small Cap Value Portfolio 353200 1.16
Vanguard International Stock Index-Total Intl Stock Indx 207933 0.68
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 177205 0.58
DFA Japanese Small Company Series 130700 0.43
DFA International Core Equity Portfolio 125900 0.41
Mercer Non-U.S. Core Equity Fd 67900 0.22
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 67800 0.22
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 40463 0.13
DFA International Vector Equity Port 24000 0.08
Vanguard International Stock Index-Pacific Stock Index 22204 0.07

ETFShare, %Profitability for 1 year, %Dividends, %
Direxion Daily Japan Bull 3x Shares 0.0097 6.34 2.48436
0.016.342.48



Head Job title Payment Year of birth
Mr. Takashi Yamaguchi President & Representative Director N/A 1952 (73 years)
Mr. Atsushi Maruo Senior Managing Member of the Board of Directors, Assistant to the President & Rep. Director N/A 1959 (66 years)
Mr. Kazuhiko Kato Senior Executive Corporate Officer N/A 1963 (62 years)
Sohta Yamaguchi Senior Managing Member of the Board of Directors & Representative Director N/A 1983 (42 years)
Fumiyoshi Yamaguchi Executive Corporate Officer & Director N/A 1986 (39 years)
Maiko Mori Executive Corporate Officer, Division Director of Quality & Safety Assurance Division & Director N/A 1964 (61 year)
Kiyohiko Tamura Executive Corporate Officer & Director of Group Business Management Division N/A

Address: Japan, Tokyo -, 5-1. Shibaura 2-Chome - open in Google maps, open in Yandex maps
Website: https://www.aska-pharma-hd.co.jp